fine chemical production including pharmaceutical compounds, medicines and agrichemicals

History:

Avecia Biologics was acquired by Merck/MSD in 2010. Merck merged them with Diosynth Biothechnology to form Merck BioManufacturing Network. The parent company of Avecia Biologics continued to operate their Avecio OligoMedicines business.

Acquisitions:
Boston BioSystems (1999)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Chemistry Instrumentation/Reagents Disease Therapeutics-Contract Manufacturing

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: